Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain

Clinical trial NCT06613737 · COMPLETED

Trial details

NCT number: NCT06613737
Sponsor: Hvivo
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Influenza A H3N2

Start date: 2024-09-11
Primary completion: 2025-03-10
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.